Glyphosate: Why the World’s Most Used Herbicide Still Sparks Regulatory Fire

https://www.laikebiotech.com/products/glyphosate.html

Glyphosate remains the most heavily applied herbicide on Earth, yet its regulatory status is anything but settled. Farmers rely on it for no-till farming and weed control, while regulators in the US and EU have reached sharply different conclusions about its safety. This article breaks down what glyphosate actually does, where the scientific consensus holds, and where the disputes remain—so you can separate verified data from advocacy noise.

What Glyphosate Does Inside a Plant (and Why That Matters for Safety)

Glyphosate is a non-selective, systemic herbicide that kills plants by blocking a specific enzyme: 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase . This enzyme is essential for the synthesis of three aromatic amino acids—phenylalanine, tyrosine, and tryptophan—that plants need to grow.

The critical safety point is that EPSP synthase does not exist in humans or animals . Humans obtain these amino acids through their diet, not through this biochemical pathway. That absence is the primary reason glyphosate exhibits relatively low acute mammalian toxicity compared to older herbicide classes.

The compound was first commercialized under the Roundup brand in 1974 and has since become the backbone of herbicide-tolerant crop systems and no-till agriculture . Global annual use now reaches approximately 749 million kilograms of active ingredient, sprayed across roughly 646 million hectares .

The Cancer Dispute: Two Regulators, Two Conclusions

No aspect of glyphosate attracts more attention than its carcinogenicity classification. The disagreement is real, but it is narrower than headlines suggest.

The International Agency for Research on Cancer (IARC) classified glyphosate as Group 2A, “probably carcinogenic to humans,” in 2015 . This classification is based on hazard identification—asking whether a substance could cause cancer under any circumstances—and IARC considered primarily published literature, including limited human evidence and animal data.

The US Environmental Protection Agency (EPA) reached the opposite conclusion after reviewing a substantially larger dataset. In its assessment, EPA found “no evidence that glyphosate causes cancer in humans” and classified it as “not likely to be carcinogenic to humans” . EPA compared its review to IARC’s and noted it evaluated 15 animal carcinogenicity studies, while IARC considered eight .

The European Food Safety Authority (EFSA) and the European Chemicals Agency (ECHA) have similarly concluded that classifying glyphosate as carcinogenic is not justified by the available evidence . However, the EU approved glyphosate’s use through 2033 with conditions, including restrictions on co-formulants .

How Regulators Currently Treat Glyphosate

For professionals navigating compliance, the practical landscape looks like this:

United States: EPA’s human health risk assessment found no risks of concern when glyphosate is used according to label directions, including for children and infants .

European Union: Approval renewed until December 2033, with member-state-level restrictions and a ban on formulations containing glyphosate plus polyethoxylated tallow amine .

Australia: The APVMA considers registered products safe when label instructions are followed .

IARC classification: Remains Group 2A, but this is a hazard classification, not a regulatory risk assessment .

The divergence between IARC and EPA/EFSA reflects different mandates: IARC asks whether a hazard exists; EPA and EFSA ask whether a risk occurs under real-world exposure scenarios.

FAQ

Is glyphosate banned anywhere?

No major agricultural economy has implemented a complete ban. The EU renewed approval through 2033 with restrictions, and some member states have imposed national limits. Mexico issued a decree to phase out glyphosate, but enforcement timelines have shifted . The regulatory trend is toward restricted use and residue monitoring, not outright prohibition.

Does glyphosate cause non-Hodgkin lymphoma?

The epidemiological signal is contested. IARC cited limited human evidence, including studies of occupationally exposed farmers, when classifying glyphosate as Group 2A . EPA reviewed the same human studies and concluded the evidence did not support a causal link, noting inconsistencies across studies and lack of dose-response clarity . Large-scale prospective cohort data remain the missing piece.

How does glyphosate compare to alternative herbicides?

Glyphosate’s low mammalian toxicity and lack of persistence in soil made it a replacement for older herbicides with worse toxicological profiles, such as paraquat and atrazine. The search for effective bioherbicides is active—recent research on microbial metabolites shows promise but remains less potent than synthetic options . For now, no alternative matches glyphosate’s combination of cost, spectrum, and systemic activity.